Related Experiment Video
Updated: Apr 30, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
12.9K
Lenalidomide.
1Department of Oncology, Hematology and Immunology, University Hospital of Tuebingen, Otfried-Mueller-Strasse 10, 72076, Tuebingen, Germany, katja.weisel@med.uni-tuebingen.de.
Summary
Lenalidomide, an immunomodulatory drug, effectively treats multiple myeloma (MM) and 5q-myelodysplastic syndrome (MDS). Its multifaceted action and clinical data are reviewed, with ongoing research in lymphomas and other conditions.
Area of Science:
- Pharmacology and Therapeutics
- Onco-immunology
Background:
- Lenalidomide is a key immunomodulatory drug (IMiD) with established efficacy in multiple myeloma (MM) and 5q-myelodysplastic syndrome (MDS).
- Its development significantly altered therapeutic strategies for MM.
- The drug exhibits immune modulation, anti-angiogenesis, anti-inflammation, and anti-proliferation.
Purpose of the Study:
- To elucidate the mechanism of action of lenalidomide.
- To review the clinical applications and data of lenalidomide.
- To explore current and future investigations of lenalidomide in various hematological malignancies.
Main Methods:
- Review of clinical phase II and III trial data.
- Analysis of pharmacological properties and biological effects.
- Literature synthesis on lenalidomide's therapeutic applications.
Main Results:
- Lenalidomide demonstrates significant clinical benefits in MM and MDS.
- Its mechanism involves complex immune modulation and direct anti-tumor effects.
- Phase II and III data support its efficacy and safety profile.
Conclusions:
- Lenalidomide represents a major advancement in MM and MDS treatment.
- Its broad spectrum of activity warrants further investigation in other hematological malignancies.
- Continued research is crucial for optimizing lenalidomide's therapeutic potential.
Related Concept Videos
01:15Drug Dosage Regimen: Overview
4.1K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.1K
01:01Dosage Regimen: Fixed Dose
2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.9K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.1K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
414
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
414